Rimshia Naaz

Mrs. Rimshia Naaz

orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 February 2026 in Cancers
Verified
Journal Article
Open access
PDF file
JAJamuna Bai Aswathanarayan
Jamuna Bai Aswathanarayan
RNRimshia Naaz
Rimshia Naaz
SDShalini H. Doreswamy
Shalini H. Doreswamy
MKMedha Karnik
Medha Karnik
SKSathish H.S. Kumar
Sathish H.S. Kumar
SubbaRao V. MadhunapantulaSubbaRao V. Madhunapantula
SubbaRao V. Madhunapantula
The phosphatidylinositol-3-kinase (PI3K)/Akt signaling pathway is a central regulator of cellular metabolism, survival, and proliferation and is frequently dysregulated in cancer. Since the identification of protein kinase B (Akt) in 1996, extensive research has established its critical role in tumor initiation, progression, and therapeutic resistance, making Akt an attractive target for anticancer drug development. Although numerous inhibitors targeting the PI3K/Akt pathway have been developed, their clinical success has been limited due to inadequate isoform specificity and unfavorable toxicity profiles. These limitations have prompted increasing interest in identifying Akt-selective inhibitors from natural sources, particularly microbial metabolites. Recent in vitro and in vivo studies demonstrate that several microbial-derived compounds effectively modulate PI3K/Akt signaling and suppress key cancer hallmarks, including proliferation, angiogenesis, and metastatic potential. Nevertheless, further studies are required to define Akt isoform specificity, evaluate selectivity against closely related kinases, and validate therapeutic efficacy in relevant preclinical models, including patient-derived xenografts. In addition, the development of robust purification and optimization strategies remains essential to enable the reliable isolation and translational advancement of these bioactive metabolites. This review summarizes Akt structure, function, and key regulatory motifs relevant to pharmacological targeting and critically examines microbial-derived inhibitors of the PI3K/Akt pathway and their mechanisms of action. Representative compounds discussed include Bostrycin, Anthracycline analogs, Wentilactone A, Thiocoraline, Iturin A, SZ-685C, Isebromoamide B, Xyloketal B, and Demethoxyfumitremorgin C. Collectively, this review highlights the therapeutic potential of microbial natural products while outlining current challenges and future directions for developing selective Akt-targeted anticancer therapies.

8 September 2026 in Nutrients
Verified
Journal Article
Open access
PDF file
RRRajalakshmi Ramashetty
Rajalakshmi Ramashetty
RNRimshia Naaz
Rimshia Naaz
RMRAMYA C M
RAMYA C M
SubbaRao V. MadhunapantulaSubbaRao V. Madhunapantula
SubbaRao V. Madhunapantula
CUChinnappa A Uthaiah
Chinnappa A Uthaiah
Introduction: Vitamin D status has been investigated as a modifiable risk factor with cognitive decline. However, studies pertaining to this remain inconsistent across populations, and there are fewer studies associating vitamin D status, cognitive decline, amyloid markers and oxidative stress markers in older adults. Therefore, this study was conducted to analyze the association between these parameters. Methodology: This cross-sectional study included 145 older adults aged between 51 and 80 years. Participants were categorized based on serum vitamin D levels into sufficient (n = 53), insufficient (n = 61), and deficient (n = 31) groups. Cognitive performance was assessed using the Modified Mini Mental State (3MS) test. Plasma levels of Aβ 1-40 and Aβ 1-42 and oxidative stress markers (TBARS, GPx, SOD) were measured. Statistical analysis was performed using ANOVA and Spearman’s correlation. Results: Results showed that the vitamin D concentrations did not differ significantly between cognitively impaired and normal individuals within vitamin D strata (vitamin D sufficient, insufficient and deficient groups). Plasma Aβ 1-40 levels were significantly elevated in cognitively impaired participants across all vitamin D groups. A reduced Aβ 1-42/Aβ 1-40 ratio was observed in sufficient and insufficient Vitamin D groups. Additionally, GPx levels were significantly higher in the vitamin D-deficient group. Correlation analysis showed that 3MS scores were negatively associated with age (r = −0.2607, p = 0.0015), Aβ 1-40 (r = −0.4016, p = 0.0001), and Aβ 1-42 (r = −0.3025, p = 0.0002), and positively correlated with Aβ 1-42/Aβ 1-40 ratio (r = 0.2176, p = 0.0086). Conclusions: These findings suggest that cognitive impairment in older adults is strongly associated with amyloid burden, oxidative stress, and age, whereas vitamin D status was not directly correlated with cognitive performance in this cohort.